CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,000 enrolled
Drug / intervention
Blood sampling +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02014519
NCT02014519N/ACompleted

Seroprevalence of Bordetella Pertussis in Adults in Hungary

GlaxoSmithKline·interventional·Posted Dec 18, 2013·Updated Nov 26, 2019

In Brief

A clinical study evaluating Blood sampling and Data collection for Pertussis and Pertussis Vaccines. Completed, enrolled 2,000 participants across 5 sites.

Detailed Summary

The purpose of this study is to perform an epidemiological survey of the adult population in Hungary to calculate the seroprevalence of pertussis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesHungary
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 18, 2013
Enrollment StartApr 24, 2014
Primary CompletionApr 22, 2015
Study CompletionApr 24, 2015
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 12.5 years ago

Interventions

Blood samplingprocedure

A blood sample (2.5 mL) will be collected from all subjects

Data collectionother

Active questioning